Syngene International informs about updates

15 Nov 2022 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, Syngene International has informed that the US Food and Drug Administration (FDA) has conducted its pre-approval inspection of the Biologics facility at Bangalore from November 07, 2022 till November 15, 2022. The inspection was completed successfully without 483 observations. The above-mentioned information will also be available on website of the Company www.syngeneintl.com.

The above information is a part of company’s filings submitted to BSE.

Syngene Internation. Share Price

645.50 -14.65 (-2.22%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 645.50
Indegene 525.00
CMS Info Systems 346.00
Sagility 50.40
Smartworks Coworking 474.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×